Medicine for inflammatory bowel disease may protect against severe COVID-19
MedicalXpress Breaking News-and-Events | May 25, 2022
Study finds COVID-19 subvariant BA.2 does not cause more severe illness than BA.1
MedicalXpress Breaking News-and-Events | May 25, 2022
FDA approves first treatment for eosinophilic esophagitis, a chronic immune disorder
FDA Press Releases | May 24, 2022
Tips for navigating the return to work during long COVID recovery
Mayo Clinic | May 24, 2022
Breakthrough COVID infections more likely in cancer and Alzheimer's patients, studies find
MedicalXpress Breaking News-and-Events | May 24, 2022
The genetic underpinnings of severe staph infections
MedicalXpress Breaking News-and-Events | May 21, 2022
Studies reveal key clues about COVID-19 immunity, immune recall
MedicalXpress Breaking News-and-Events | May 21, 2022
Vaccines may lessen long COVID for some, but more study is needed
MedicalXpress Breaking News-and-Events | May 21, 2022
Hepatocellular carcinoma guidelines stress individualized treatment plans
MDlinx | May 21, 2022